IMMUNOME - Trademark Details
Status: 700 - Registered
Serial Number
87054546
Registration Number
6002837
Word Mark
IMMUNOME
Status
700 - Registered
Status Date
2020-03-03
Filing Date
2016-05-31
Registration Number
6002837
Registration Date
2020-03-03
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2016-11-08
Attorney Name
Law Office Assigned Location Code
L20
Employee Name
RINKER, ANTHONY MICHAE
Statements
Goods and Services
Monoclonal antibodies for medical and scientific research; antibodies and immunoconjugates for medical and scientific research; proteins and components of proteins for medical and scientific research; cells, cell extracts and components of cells for medical and scientific research
Goods and Services
Monoclonal antibodies and immunoconjugates for medical or clinical use; pharmaceutical compositions comprising monoclonal antibodies for use in the diagnosis, prevention, management and treatment of oncological, neurological, infectious disease, metabolic, viral, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, hepatological, opthalmic, respiratory, gastrointestinal, hormonal, dermatological, psychiatric and immune system related conditions, diseases and disorders; pharmaceutical compositions comprising immunoconjugates in the diagnosis, prevention, management and treatment of oncological, neurological, infectious disease, metabolic, viral, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, hepatological, opthalmic, respiratory, gastrointestinal, hormonal, dermatological, psychiatric and immune system related conditions, diseases and disorders; cells, cell extracts and components of cells for medical or clinical use; pharmaceutical preparations for use in the diagnosis, prevention, management and treatment of oncological, neurological, infectious disease, metabolic, viral, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, hepatological, opthalmic, respiratory, gastrointestinal, hormonal, dermatological, psychiatric and immune system related conditions, diseases and disorders; diagnostic preparations for medical use; diagnostic kits comprising reagents for medical and clinical use
Goods and Services
Biotechnology services, namely, development of monoclonal antibodies; pharmaceutical, medical, scientific, biopharmaceutical and biotechnology research and development; drug discovery services; providing medical and scientific research information in the field of medicine and pharmaceuticals
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2016-06-07
Primary Code
042
First Use Anywhere Date
2019-10-21
First Use In Commerce Date
2019-10-21
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
LORI J. SHYAVITZ
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Continuity Child | 87976614 |
Trademark Events
Event Date | Event Description |
2016-06-03 | NEW APPLICATION ENTERED IN TRAM |
2016-06-07 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2016-09-13 | ASSIGNED TO EXAMINER |
2016-09-16 | EXAMINERS AMENDMENT -WRITTEN |
2016-09-16 | EXAMINERS AMENDMENT E-MAILED |
2016-09-16 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2016-09-16 | EXAMINER'S AMENDMENT ENTERED |
2016-09-16 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2016-09-30 | ASSIGNED TO LIE |
2016-10-03 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2016-10-19 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2016-11-08 | PUBLISHED FOR OPPOSITION |
2016-11-08 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2017-01-03 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2017-07-03 | TEAS EXTENSION RECEIVED |
2017-07-03 | EXTENSION 1 FILED |
2017-07-03 | EXTENSION 1 GRANTED |
2017-07-05 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2018-01-03 | TEAS EXTENSION RECEIVED |
2018-01-03 | TEAS REQUEST TO DIVIDE RECEIVED |
2018-01-16 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2018-01-03 | DIVISIONAL REQUEST RECEIVED |
2018-01-17 | DIVISIONAL PROCESSING COMPLETE |
2018-01-03 | EXTENSION 2 FILED |
2018-01-17 | EXTENSION 2 GRANTED |
2018-01-18 | CORRECTED NOA E-MAILED |
2018-01-18 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2018-06-29 | TEAS EXTENSION RECEIVED |
2018-06-29 | EXTENSION 3 FILED |
2018-06-29 | EXTENSION 3 GRANTED |
2018-07-03 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2019-01-02 | TEAS EXTENSION RECEIVED |
2019-01-02 | EXTENSION 4 FILED |
2019-01-02 | EXTENSION 4 GRANTED |
2019-01-04 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2019-07-03 | TEAS EXTENSION RECEIVED |
2019-07-03 | EXTENSION 5 FILED |
2019-07-05 | EXTENSION 5 GRANTED |
2019-07-06 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2020-01-03 | TEAS STATEMENT OF USE RECEIVED |
2020-01-03 | USE AMENDMENT FILED |
2020-01-04 | STATEMENT OF USE PROCESSING COMPLETE |
2020-01-27 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
2020-01-28 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
2020-03-03 | REGISTERED-PRINCIPAL REGISTER |